CADL logo

Candel Therapeutics (CADL) EBITDA

Annual EBITDA

-$34.38 M
-$18.08 M-110.84%

December 31, 2023


Summary


Performance

CADL EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCADLprofitabilitymetrics:

Quarterly EBITDA

-$9.91 M
+$11.51 M+53.72%

September 30, 2024


Summary


Performance

CADL Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCADLprofitabilitymetrics:

TTM EBITDA

-$48.83 M
-$2.39 M-5.15%

September 30, 2024


Summary


Performance

CADL TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCADLprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CADL EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-110.8%+53.7%-5.2%
3 y3 years-162.6%-131.4%-98.5%
5 y5 years-308.2%-131.4%-98.5%

CADL EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-110.8%at low-181.1%+53.7%-105.8%at low
5 y5-year-308.2%at low-494.4%+53.7%-2827.6%at low
alltimeall time-308.2%at low-494.4%+53.7%-2827.6%at low

Candel Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$9.91 M(-53.7%)
-$48.83 M(+5.2%)
Jun 2024
-
-$21.42 M(+192.5%)
-$46.44 M(+37.6%)
Mar 2024
-
-$7.32 M(-28.0%)
-$33.75 M(-1.8%)
Dec 2023
-$34.38 M(+110.8%)
-$10.17 M(+35.3%)
-$34.38 M(+20.7%)
Sep 2023
-
-$7.52 M(-13.9%)
-$28.50 M(-1.5%)
Jun 2023
-
-$8.73 M(+9.8%)
-$28.94 M(+21.9%)
Mar 2023
-
-$7.96 M(+85.7%)
-$23.73 M(-3.5%)
Dec 2022
-$16.31 M
-$4.28 M(-46.2%)
-$24.60 M(-11.3%)
Sep 2022
-
-$7.96 M(+125.8%)
-$27.73 M(+0.3%)
Jun 2022
-
-$3.53 M(-60.0%)
-$27.64 M(-4.0%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$8.82 M(+19.0%)
-$28.80 M(+17.9%)
Dec 2021
-$24.42 M(+86.5%)
-$7.41 M(-5.9%)
-$24.42 M(+6.3%)
Sep 2021
-
-$7.88 M(+68.0%)
-$22.97 M(+30.2%)
Jun 2021
-
-$4.69 M(+5.6%)
-$17.65 M(+14.5%)
Mar 2021
-
-$4.44 M(-25.6%)
-$15.41 M(+21.9%)
Dec 2020
-$13.10 M(+55.5%)
-$5.97 M(+134.0%)
-$12.64 M(+89.4%)
Sep 2020
-
-$2.55 M(+3.9%)
-$6.67 M(+61.8%)
Jun 2020
-
-$2.46 M(+47.2%)
-$4.12 M(+147.2%)
Mar 2020
-
-$1.67 M
-$1.67 M
Dec 2019
-$8.42 M
-
-

FAQ

  • What is Candel Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Candel Therapeutics?
  • What is Candel Therapeutics annual EBITDA year-on-year change?
  • What is Candel Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Candel Therapeutics?
  • What is Candel Therapeutics quarterly EBITDA year-on-year change?
  • What is Candel Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Candel Therapeutics?
  • What is Candel Therapeutics TTM EBITDA year-on-year change?

What is Candel Therapeutics annual EBITDA?

The current annual EBITDA of CADL is -$34.38 M

What is the all time high annual EBITDA for Candel Therapeutics?

Candel Therapeutics all-time high annual EBITDA is -$8.42 M

What is Candel Therapeutics annual EBITDA year-on-year change?

Over the past year, CADL annual EBITDA has changed by -$18.08 M (-110.84%)

What is Candel Therapeutics quarterly EBITDA?

The current quarterly EBITDA of CADL is -$9.91 M

What is the all time high quarterly EBITDA for Candel Therapeutics?

Candel Therapeutics all-time high quarterly EBITDA is -$1.67 M

What is Candel Therapeutics quarterly EBITDA year-on-year change?

Over the past year, CADL quarterly EBITDA has changed by +$11.51 M (+53.72%)

What is Candel Therapeutics TTM EBITDA?

The current TTM EBITDA of CADL is -$48.83 M

What is the all time high TTM EBITDA for Candel Therapeutics?

Candel Therapeutics all-time high TTM EBITDA is -$1.67 M

What is Candel Therapeutics TTM EBITDA year-on-year change?

Over the past year, CADL TTM EBITDA has changed by -$2.39 M (-5.15%)